{"id":767752,"date":"2023-07-05T10:18:36","date_gmt":"2023-07-05T14:18:36","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/aeterna-zentaris-to-participate-in-the-virtual-investor-summer-spotlight-series\/"},"modified":"2023-07-05T10:18:36","modified_gmt":"2023-07-05T14:18:36","slug":"aeterna-zentaris-to-participate-in-the-virtual-investor-summer-spotlight-series","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/aeterna-zentaris-to-participate-in-the-virtual-investor-summer-spotlight-series\/","title":{"rendered":"Aeterna Zentaris to Participate in the Virtual Investor Summer Spotlight Series"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"center\">\n        <em>Live <\/em><br \/>\n        <em>moderated <\/em><br \/>\n        <em>video webcast on Thursday, July 13<\/em><br \/>\n        <sup><br \/>\n          <em>th<\/em><br \/>\n        <\/sup><br \/>\n        <em> at 10:00 AM ET<\/em>\n      <\/p>\n<p align=\"justify\">\n        <strong>TORONTO, ONTARIO, July  05, 2023  (GLOBE NEWSWIRE) &#8212; <\/strong>Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (\u201cAeterna\u201d or the \u201cCompany\u201d), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products, today announced that <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=DmJ-kqRtX4YF6_OHPM-PhK1sqPdV0dVdqaOeFo9pmKgejkf0ANgkhlv-90jqIFepgLGmIuVKkfhSG9o1lInkaTZBQu315kr5Jr1V4FnOmLLqc2jbCuRBVc2HX1831QDuaqYduu7_iwZqU7sI0QsTbw==\" rel=\"nofollow noopener\" target=\"_blank\">Dr. Klaus Paulini, Chief Executive Officer<\/a> and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=uxyGU9v37d6Bdvxa3lBvA4agRGx2b6k6R_0sdS38LDIgP6NyJFFFb4GETqhRW1Vv7M_R7C7AcVABh_-9Ec_RSHUf-RmTiPda-gac6omSZM0AP095CxFpdy1lK4LIKsAyYnFy6hLHmNlMTgtqIBJMAuP0Y9vklYEv3pfDA6e8-sw-50RUv8urimLxegLUB2hZ\" rel=\"nofollow noopener\" target=\"_blank\">Eckhard Guenther, PhD, Managing Director and SVP, Business Development<\/a> of Aeterna Zentaris, will participate in the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=U7N0aRclPHHbIhuC6MHLt-DQ-sw_erTYYOAM6d9fhIFUC1v2gqhjKxMgrfR4s3xZ-34_f6eTNXcPjmyphcgil3LSfiEGBv5pnte-5ghw5VIfGF_9yohc2l_xzuv0KUufBi-n5B7uYGUjxaWm_jofP1CKM2FdFC7L8zox9nNhkDe2Pa_4MNloA1ep1K6xaiO3\" rel=\"nofollow noopener\" target=\"_blank\">Virtual Investor Summer Spotlight Series<\/a> on Wednesday, July 13, 2023, at 10:00 AM ET.<\/p>\n<p align=\"justify\">A <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5rgkTzWSOLUkxt4mAEwnoe8R9YDD37X3oQj5NwUD5wzvWAuqZqr9NcWfc3zbPJKE152Jm12aE-oWOLlylp8GTu5M0RRel3tj1xLllgcCVHewSbDiYo2dJKiv1MP72OMVpwDYbhWGtl1mBKH6Mz6uvg==\" rel=\"nofollow noopener\" target=\"_blank\">live video webcast <\/a>of the presentation will be available on the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=APRFthq4gj2JGByLCYBECVUp1cehF_1pouzK8y03-c_ygW7bE9ZXdnkLeOxCvMeozUgK-wBZy5oWr1vR8ibMSXcXBwpHmFx_ZPYXbeaw3SU=\" rel=\"nofollow noopener\" target=\"_blank\">Events<\/a> page of the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=jVPvWxLMXHMzCkFYVWCp-3kQ_Y5-AtoVtFbQOnKxkj3VM6Ma6q3FUftkxl7f7mjZqiCi1OpNw5b3vd8aSUniksmRkBUvDGLha77PoMcQmM0=\" rel=\"nofollow noopener\" target=\"_blank\">Investors<\/a> section of the Company\u2019s website (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=OT6lcOiAeUnnL40krUedJjeimpvvClPAlS1ObaPoR_SYYHdiVT8eDwpyZFRdZsnKx7Uqysyj1dDTEcmoAdw5kw==\" rel=\"nofollow noopener\" target=\"_blank\">zentaris.com)<\/a>. A webcast replay will be available two hours following the live presentation and will be accessible for 90 days.<\/p>\n<p align=\"justify\">\n        <strong>About <\/strong><br \/>\n        <strong>Aeterna<\/strong><br \/>\n        <strong>Zentaris<\/strong><br \/>\n        <strong> Inc.<\/strong>\n      <\/p>\n<p align=\"justify\">Aeterna Zentaris is a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products focused on areas of significant unmet medical need. The Company&#8217;s lead product, macimorelin (Macrilen<sup>\u00ae<\/sup>; Ghryvelin<sup>\u2122<\/sup>), is the first and only U.S. FDA and European Commission approved oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is leveraging the clinical success and compelling safety profile of macimorelin to develop it for the diagnosis of childhood-onset growth hormone deficiency (CGHD), an area of significant unmet need.<\/p>\n<p align=\"justify\">Aeterna Zentaris is dedicated to the development of its therapeutic asset and has established a pre-clinical development pipeline to potentially address unmet medical needs across a number of indications, including neuromyelitis optica spectrum disorder (NMOSD), Parkinson&#8217;s disease (PD), hypoparathyroidism and amyotrophic lateral sclerosis (ALS; Lou Gehrig&#8217;s disease).<\/p>\n<p align=\"justify\">For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=SKv3T-CYur3J_pZCGSAKteC-1jBScMDrrSm7L53ORL2yUTccLvfsIG6QLbXCpNya0KGg0cg8ju3FiekH5sLXZg==\" rel=\"nofollow noopener\" target=\"_blank\">www.zentaris.com<\/a> and connect with the Company on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=dVLK_0e0tfy73hdzzCiZd8FkJaDEIkASZER62tjgU2boKxpz8gI-e1VRkAxnADs8lMOnJxIbK-GdP932IlAFiw==\" rel=\"nofollow noopener\" target=\"_blank\">Twitter<\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=AcT5QazFIXfZ2X0chwYDJwlkCDc-P93DUOqkHV5oCvLyyhWdX0K9q2P1tY28s2LrjJuADj9rDM0qWk3m5C8QOKpXkhhXKqc-eMUdDwJ8AL1zD8UC66z8NWtjXI237xn8\" rel=\"nofollow noopener\" target=\"_blank\">LinkedIn<\/a> and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=DUBlK5Anh_tCOqJ_98PQ0RCGC-7ZkdOf4uiDDWSwFFSp5bTm-xQo0bOWKKugi-lKymWdfUZKr7KZlL-9rkQ97jvl3waMlvp3b-LtqFB1S10=\" rel=\"nofollow noopener\" target=\"_blank\">Facebook<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>Jenene Thomas<br \/>JTC Team<br \/>T (US): +1 (833) 475-8247<br \/>E: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=txomP7uNLYRPCXMwjuf263r6lUlokFBTWJGDb6F8Vc0_gK4B8QAD0Ddri8kHs5i6urayKgHDjh37df1aWUqcQQ==\" rel=\"nofollow noopener\" target=\"_blank\">aezs@jtcir.com<\/a><\/p>\n<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg2ODU4MSM1Njc1OTkzIzUwMDA3MjY3Nw==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/M2RlNWVhYjQtZmRjZS00NGYxLThjY2MtZjUxYWZiN2ZiZjQ0LTUwMDA3MjY3Nw==\/tiny\/Aeterna-Zentaris-Inc.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Live moderated video webcast on Thursday, July 13 th at 10:00 AM ET TORONTO, ONTARIO, July 05, 2023 (GLOBE NEWSWIRE) &#8212; Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (\u201cAeterna\u201d or the \u201cCompany\u201d), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products, today announced that Dr. Klaus Paulini, Chief Executive Officer and Eckhard Guenther, PhD, Managing Director and SVP, Business Development of Aeterna Zentaris, will participate in the Virtual Investor Summer Spotlight Series on Wednesday, July 13, 2023, at 10:00 AM ET. A live video webcast of the presentation will be available on the Events page of the Investors section of the Company\u2019s website (zentaris.com). A webcast replay will be available two hours following the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/aeterna-zentaris-to-participate-in-the-virtual-investor-summer-spotlight-series\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Aeterna Zentaris to Participate in the Virtual Investor Summer Spotlight Series&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-767752","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Aeterna Zentaris to Participate in the Virtual Investor Summer Spotlight Series - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/aeterna-zentaris-to-participate-in-the-virtual-investor-summer-spotlight-series\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aeterna Zentaris to Participate in the Virtual Investor Summer Spotlight Series - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Live moderated video webcast on Thursday, July 13 th at 10:00 AM ET TORONTO, ONTARIO, July 05, 2023 (GLOBE NEWSWIRE) &#8212; Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (\u201cAeterna\u201d or the \u201cCompany\u201d), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products, today announced that Dr. Klaus Paulini, Chief Executive Officer and Eckhard Guenther, PhD, Managing Director and SVP, Business Development of Aeterna Zentaris, will participate in the Virtual Investor Summer Spotlight Series on Wednesday, July 13, 2023, at 10:00 AM ET. A live video webcast of the presentation will be available on the Events page of the Investors section of the Company\u2019s website (zentaris.com). A webcast replay will be available two hours following the &hellip; Continue reading &quot;Aeterna Zentaris to Participate in the Virtual Investor Summer Spotlight Series&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/aeterna-zentaris-to-participate-in-the-virtual-investor-summer-spotlight-series\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-07-05T14:18:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg2ODU4MSM1Njc1OTkzIzUwMDA3MjY3Nw==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aeterna-zentaris-to-participate-in-the-virtual-investor-summer-spotlight-series\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aeterna-zentaris-to-participate-in-the-virtual-investor-summer-spotlight-series\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Aeterna Zentaris to Participate in the Virtual Investor Summer Spotlight Series\",\"datePublished\":\"2023-07-05T14:18:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aeterna-zentaris-to-participate-in-the-virtual-investor-summer-spotlight-series\\\/\"},\"wordCount\":302,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aeterna-zentaris-to-participate-in-the-virtual-investor-summer-spotlight-series\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg2ODU4MSM1Njc1OTkzIzUwMDA3MjY3Nw==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aeterna-zentaris-to-participate-in-the-virtual-investor-summer-spotlight-series\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aeterna-zentaris-to-participate-in-the-virtual-investor-summer-spotlight-series\\\/\",\"name\":\"Aeterna Zentaris to Participate in the Virtual Investor Summer Spotlight Series - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aeterna-zentaris-to-participate-in-the-virtual-investor-summer-spotlight-series\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aeterna-zentaris-to-participate-in-the-virtual-investor-summer-spotlight-series\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg2ODU4MSM1Njc1OTkzIzUwMDA3MjY3Nw==\",\"datePublished\":\"2023-07-05T14:18:36+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aeterna-zentaris-to-participate-in-the-virtual-investor-summer-spotlight-series\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aeterna-zentaris-to-participate-in-the-virtual-investor-summer-spotlight-series\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aeterna-zentaris-to-participate-in-the-virtual-investor-summer-spotlight-series\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg2ODU4MSM1Njc1OTkzIzUwMDA3MjY3Nw==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg2ODU4MSM1Njc1OTkzIzUwMDA3MjY3Nw==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aeterna-zentaris-to-participate-in-the-virtual-investor-summer-spotlight-series\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Aeterna Zentaris to Participate in the Virtual Investor Summer Spotlight Series\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Aeterna Zentaris to Participate in the Virtual Investor Summer Spotlight Series - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/aeterna-zentaris-to-participate-in-the-virtual-investor-summer-spotlight-series\/","og_locale":"en_US","og_type":"article","og_title":"Aeterna Zentaris to Participate in the Virtual Investor Summer Spotlight Series - Market Newsdesk","og_description":"Live moderated video webcast on Thursday, July 13 th at 10:00 AM ET TORONTO, ONTARIO, July 05, 2023 (GLOBE NEWSWIRE) &#8212; Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (\u201cAeterna\u201d or the \u201cCompany\u201d), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products, today announced that Dr. Klaus Paulini, Chief Executive Officer and Eckhard Guenther, PhD, Managing Director and SVP, Business Development of Aeterna Zentaris, will participate in the Virtual Investor Summer Spotlight Series on Wednesday, July 13, 2023, at 10:00 AM ET. A live video webcast of the presentation will be available on the Events page of the Investors section of the Company\u2019s website (zentaris.com). A webcast replay will be available two hours following the &hellip; Continue reading \"Aeterna Zentaris to Participate in the Virtual Investor Summer Spotlight Series\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/aeterna-zentaris-to-participate-in-the-virtual-investor-summer-spotlight-series\/","og_site_name":"Market Newsdesk","article_published_time":"2023-07-05T14:18:36+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg2ODU4MSM1Njc1OTkzIzUwMDA3MjY3Nw==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aeterna-zentaris-to-participate-in-the-virtual-investor-summer-spotlight-series\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aeterna-zentaris-to-participate-in-the-virtual-investor-summer-spotlight-series\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Aeterna Zentaris to Participate in the Virtual Investor Summer Spotlight Series","datePublished":"2023-07-05T14:18:36+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aeterna-zentaris-to-participate-in-the-virtual-investor-summer-spotlight-series\/"},"wordCount":302,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aeterna-zentaris-to-participate-in-the-virtual-investor-summer-spotlight-series\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg2ODU4MSM1Njc1OTkzIzUwMDA3MjY3Nw==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aeterna-zentaris-to-participate-in-the-virtual-investor-summer-spotlight-series\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/aeterna-zentaris-to-participate-in-the-virtual-investor-summer-spotlight-series\/","name":"Aeterna Zentaris to Participate in the Virtual Investor Summer Spotlight Series - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aeterna-zentaris-to-participate-in-the-virtual-investor-summer-spotlight-series\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aeterna-zentaris-to-participate-in-the-virtual-investor-summer-spotlight-series\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg2ODU4MSM1Njc1OTkzIzUwMDA3MjY3Nw==","datePublished":"2023-07-05T14:18:36+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aeterna-zentaris-to-participate-in-the-virtual-investor-summer-spotlight-series\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/aeterna-zentaris-to-participate-in-the-virtual-investor-summer-spotlight-series\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aeterna-zentaris-to-participate-in-the-virtual-investor-summer-spotlight-series\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg2ODU4MSM1Njc1OTkzIzUwMDA3MjY3Nw==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg2ODU4MSM1Njc1OTkzIzUwMDA3MjY3Nw=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aeterna-zentaris-to-participate-in-the-virtual-investor-summer-spotlight-series\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Aeterna Zentaris to Participate in the Virtual Investor Summer Spotlight Series"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/767752","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=767752"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/767752\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=767752"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=767752"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=767752"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}